Mevalonate pathway inhibition slows breast cancer metastasis via reduced N-glycosylation abundance and branching http://pennlab.ca/wp-content/uploads/2021/02/Rosemary_Dolichol.png 396 361 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2021/02/Rosemary_Dolichol.png February 21, 2021 February 21, 2021 February 21, 2021 0 read more
Statins as Anticancer Agents in the Era of Precision Medicine http://pennlab.ca/wp-content/uploads/2020/11/Screen-Shot-2020-11-05-at-12.14.41-PM.png 717 688 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/11/Screen-Shot-2020-11-05-at-12.14.41-PM.png November 5, 2020 November 5, 2020 November 5, 2020 0 read more
Computational pharmacogenomics screen identifies synergistic statin-compound combinations as anti-breast cancer therapies http://pennlab.ca/wp-content/uploads/2020/10/Screen-Shot-2020-10-02-at-11.06.43-AM.png 981 843 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/10/Screen-Shot-2020-10-02-at-11.06.43-AM.png October 2, 2020 October 2, 2020 October 2, 2020 0 read more
Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death http://pennlab.ca/wp-content/uploads/2020/08/JL_cAMP-paper.png 952 562 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/08/JL_cAMP-paper.png August 26, 2020 August 26, 2020 August 26, 2020 0 read more
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma http://pennlab.ca/wp-content/uploads/2020/07/JL_t414-paper_cropped.png 295 211 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/07/JL_t414-paper_cropped.png July 14, 2020 July 14, 2020 July 14, 2020 0 read more
A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer http://pennlab.ca/wp-content/uploads/2020/03/JL_WinSTOP-trial_square-1024x796.png 1024 796 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/03/JL_WinSTOP-trial_square-1024x796.png March 19, 2020 March 19, 2020 March 19, 2020 0 read more